Ascentage Pharma's Lisaftoclax Shows Promising Efficacy at ASCO 2024
![https://store.livarava.com/c0285aab-22ef-11ef-a406-9d5fa15a64d8.jpg](https://store.livarava.com/c0285aab-22ef-11ef-a406-9d5fa15a64d8.jpg)
Ascentage Pharma Presents Updated Data at ASCO 2024
Ascentage Pharma showcased the latest findings on Lisaftoclax, emphasizing its promising efficacy and safety in treating patients with WM. The results indicate a potential advancement in addressing this condition, with implications for both current treatments and future developments.
Key Highlights:
- Positive Impact: Lisaftoclax demonstrates encouraging outcomes in WM patients.
- Safety First: Researchers emphasize the drug's safety profile.
In conclusion, Ascentage Pharma's presentation at ASCO 2024 sheds light on the potential of Lisaftoclax in improving outcomes for WM patients.